See every side of every news story
Get Started
SubscribeLogin
Israel-Hamas Conflict
Tariffs
Donald Trump
Trade War
Baseball
Social Media
Natural Disasters
Artificial Intelligence
Senate
Republican Party
Trade
Stock Markets
Golf
Published • Leiden, Netherlands • Updated

Pharming Group doses first patient in phase 2 trial of leniolisib in CVID - Pharmafile

Summary by pharmafile.com
Pharming Group has announced that the first patient has been dosed in a phase 2 clinical trial evaluating leniolisib in common variable immunodeficiency (CVID) patients with immune dysregulation. The company, based in Leiden, the Netherlands, specialises in developing and commercialising medicines for “patients with rare, debilitating and life threatening diseases”. The trial will assess leniolisib’s […] The post Pharming Group doses first patie…
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

1 Articles

All
Left
Center
Right
pharmafile.compharmafile.com

Pharming Group doses first patient in phase 2 trial of leniolisib in CVID - Pharmafile

Pharming Group has announced that the first patient has been dosed in a phase 2 clinical trial evaluating leniolisib in common variable immunodeficiency (CVID) patients with immune dysregulation. The company, based in Leiden, the Netherlands, specialises in developing and commercialising medicines for “patients with rare, debilitating and life threatening diseases”. The trial will assess leniolisib’s […] The post Pharming Group doses first patie…

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

pharmafile.com broke the news in on Wednesday, March 26, 2025.
Sources are mostly out of (0)
Stories disproportionately reported by the Left or the Right

Similar News Topics

Leiden

Leiden

You have read 4 out of your 5 free daily articles.

Join us as a member to unlock exclusive access to diverse content.

Our use of cookies
Unlike other news sites, we do not share or sell your data to third-parties for targeted ads.
By continuing to use our application or website, you agree to our Terms of Service and Privacy Policy.
News
For You
SearchBlindspotLocal